108 related articles for article (PubMed ID: 12224687)
21. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.
Parodi A; Paolino S; Greco A; Drago F; Mansi C; Rebora A; Parodi A; Savarino V
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):759-64. PubMed ID: 18456568
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea.
Gravina A; Federico A; Ruocco E; Lo Schiavo A; Masarone M; Tuccillo C; Peccerillo F; Miranda A; Romano L; de Sio C; de Sio I; Persico M; Ruocco V; Riegler G; Loguercio C; Romano M
United European Gastroenterol J; 2015 Feb; 3(1):17-24. PubMed ID: 25653855
[TBL] [Abstract][Full Text] [Related]
23. The study of prevalence of Helicobacter pylori in patients with acne rosacea.
Bhattarai S; Agrawal A; Rijal A; Majhi S; Pradhan B; Dhakal SS
Kathmandu Univ Med J (KUMJ); 2012; 10(40):49-52. PubMed ID: 23575053
[TBL] [Abstract][Full Text] [Related]
24. Extraintestinal manifestations of Helicobacter pylori: a concise review.
Wong F; Rayner-Hartley E; Byrne MF
World J Gastroenterol; 2014 Sep; 20(34):11950-61. PubMed ID: 25232230
[TBL] [Abstract][Full Text] [Related]
25. Effect of Helicobacter pylori eradication therapy in rosacea patients.
Boixeda de Miquel D; Vázquez Romero M; Vázquez Sequeiros E; Foruny Olcina JR; Boixeda de Miquel P; López San Román A; Alemán Villanueva S; Martín de Argila de Prados C
Rev Esp Enferm Dig; 2006 Jul; 98(7):501-9. PubMed ID: 17022699
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori and rosacea.
Zandi S; Shamsadini S; Zahedi MJ; Hyatbaksh M
East Mediterr Health J; 2003; 9(1-2):167-71. PubMed ID: 15562747
[TBL] [Abstract][Full Text] [Related]
27. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series.
Daković Z; Vesić S; Vuković J; Milenković S; Janković-Terzić K; Dukić S; Pavlović MD
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):83-6. PubMed ID: 17992465
[TBL] [Abstract][Full Text] [Related]
28. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis.
Jørgensen AR; Egeberg A; Gideonsson R; Weinstock LB; Thyssen EP; Thyssen JP
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2010-2015. PubMed ID: 28543746
[TBL] [Abstract][Full Text] [Related]
29. Effects of Helicobacter pylori treatment on rosacea: A single-arm clinical trial study.
Saleh P; Naghavi-Behzad M; Herizchi H; Mokhtari F; Mirza-Aghazadeh-Attari M; Piri R
J Dermatol; 2017 Sep; 44(9):1033-1037. PubMed ID: 28452093
[TBL] [Abstract][Full Text] [Related]
30. The role of Helicobacter pylori infection in skin diseases: facts and controversies.
Tüzün Y; Keskin S; Kote E
Clin Dermatol; 2010; 28(5):478-82. PubMed ID: 20797505
[TBL] [Abstract][Full Text] [Related]
31. The effect of mastic gum on Helicobacter pylori: a randomized pilot study.
Dabos KJ; Sfika E; Vlatta LJ; Giannikopoulos G
Phytomedicine; 2010 Mar; 17(3-4):296-9. PubMed ID: 19879118
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection and dermatologic diseases.
HERNANDO-HARDER AC; BOOKEN N; GOERDT S; SINGER MV; HARDER H
Eur J Dermatol; 2009; 19(5):431-44. PubMed ID: 19527988
[TBL] [Abstract][Full Text] [Related]
33. Remission of rosacea induced by reduction of gut transit time.
Kendall SN
Clin Exp Dermatol; 2004 May; 29(3):297-9. PubMed ID: 15115515
[TBL] [Abstract][Full Text] [Related]
34. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study.
Diaz C; O'Callaghan CJ; Khan A; Ilchyshyn A
Acta Derm Venereol; 2003; 83(4):282-6. PubMed ID: 12926800
[TBL] [Abstract][Full Text] [Related]
35. Rosacea: current state of epidemiology.
Tan J; Berg M
J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S27-35. PubMed ID: 24229634
[TBL] [Abstract][Full Text] [Related]
36. Potential role of microorganisms in the pathogenesis of rosacea.
Holmes AD
J Am Acad Dermatol; 2013 Dec; 69(6):1025-32. PubMed ID: 24011460
[TBL] [Abstract][Full Text] [Related]
37. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut-Skin Axis of Rosacea.
Wang FY; Chi CC
Adv Ther; 2021 Mar; 38(3):1415-1424. PubMed ID: 33507499
[TBL] [Abstract][Full Text] [Related]
38. Rosacea and gastrointestinal disorders: a population-based cohort study.
Egeberg A; Weinstock LB; Thyssen EP; Gislason GH; Thyssen JP
Br J Dermatol; 2017 Jan; 176(1):100-106. PubMed ID: 27501017
[TBL] [Abstract][Full Text] [Related]
39. Rosacea and the Microbiome: A Systematic Review.
Daou H; Paradiso M; Hennessy K; Seminario-Vidal L
Dermatol Ther (Heidelb); 2021 Feb; 11(1):1-12. PubMed ID: 33170492
[TBL] [Abstract][Full Text] [Related]
40. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.
Holmes AD; Steinhoff M
Exp Dermatol; 2017 Aug; 26(8):659-667. PubMed ID: 27376863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
